Delisting Determination,The Nasdaq Stock Market, LLC,
September 14, 2012, NeurogesX, Inc. The Nasdaq Stock
Market, Inc. (the Exchange) has determined to remove
from listing the common stock of NeurogesX, Inc.
(the Company), effective at the opening of the trading
session on September 24, 2012. Based on review of information
provided by the Company, Nasdaq Staff determined that the
Company no longer qualified for listing on the Exchange
pursuant to Listing Rule 5450(b)(2)(A). The
Company was notified of the Staffs determination on
April 17, 2012.  The Company appealed
the determination to a Hearing Panel.
Upon review of the information provided by the Company,
the Panel issued a decision dated June 27, 2012, denying
the Company continued listing and
notifying the Company that trading in the Companys
securities would be suspended on June 29, 2012.
The Company did not request a review of the Panels decision
by the Nasdaq Listing and Hearing Review Council. The
Listing Council did not call the matter for review.
The Panels Determination to delist the Company became
final on August 13, 2012.